Cargando…
Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients
Immunotherapy for melanoma includes adoptive cell therapy with autologous tumor-infiltrating lymphocytes (TILs). This monocenter retrospective study was undertaken to evaluate the efficacy and safety of this treatment of patients with advanced melanoma. All advanced melanoma patients treated with TI...
Autores principales: | Saint-Jean, Mélanie, Knol, Anne-Chantal, Volteau, Christelle, Quéreux, Gaëlle, Peuvrel, Lucie, Brocard, Anabelle, Pandolfino, Marie-Christine, Saiagh, Soraya, Nguyen, Jean-Michel, Bedane, Christophe, Basset-Seguin, Nicole, Khammari, Amir, Dréno, Brigitte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883986/ https://www.ncbi.nlm.nih.gov/pubmed/29750176 http://dx.doi.org/10.1155/2018/3530148 |
Ejemplares similares
-
Tissue Biomarkers in Melanoma Patients Treated with TIL
por: Knol, Anne-Chantal, et al.
Publicado: (2012) -
Dramatic response of an inoperable Merkel cell carcinoma with imatinib
por: Frenard, Cecile, et al.
Publicado: (2016) -
Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival
por: Khammari, Amir, et al.
Publicado: (2014) -
Visceral metastatic angiosarcoma treated effectively with oral cyclophosphamide combined with propranolol
por: Daguzé, Justine, et al.
Publicado: (2016) -
Chemotherapy efficacy after first-line immunotherapy in 18 advanced melanoma patients
por: Saint-Jean, Mélanie, et al.
Publicado: (2020)